UDN-72645-34933
1 vaccination
1 coded response
4 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 968 / HI
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- Asian
- Ethnicity
- N/A
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Survey response — day 0, dose 1MedDRA: Urticaria — Feeling: Fair · Site: PainFree text: HivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech |
Call center
3 call center cases
3 priority 2/3 (triaged and no follow up)
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Hives
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release